Total Brain (ASX:TTB) is the developer of a neuroscience-based mental health monitoring and support platform powered by the largest standardised neuroscientific database in the world formed over almost two decades and with >$50m of R&D funding. The company has reported Q2 FY22 cash receipts of $3.96m, representing a four-fold increase year-on-year and a six-fold increase quarter-on-quarter. Total Brain reported its best-ever operating cash profit of $0.92m. The jump in receipts was driven by rec ....
